Cancer’s hidden ‘safety switch’: Silencing TAK1 gene could boost immunotherapy performance

Australian researchers have discovered that the TAK1 gene helps cancer cells survive attack from the immune system, revealing a mechanism that may limit the effectiveness of immunotherapy treatments.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup